Xlife Sciences AG (SWX:XLS)
Switzerland · Delayed Price · Currency is CHF 16.85
-0.15 (-0.88%)
At close: Jul 31, 2026
Xlife Sciences AG Balance Sheet
Financials in millions CHF. Fiscal year is January - December.
Millions CHF. Fiscal year is Jan - Dec.
Assets
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 0.4 | 0.1 | 0.22 | 0.22 | 1.96 |
Short-Term Investments | 0.65 | - | - | - | - |
Cash & Short-Term Investments | 1.05 | 0.1 | 0.22 | 0.22 | 1.96 |
Cash Growth | 961.19% | -54.72% | -1.05% | -88.70% | -58.40% |
Accounts Receivable | 0.09 | 8.46 | 9.13 | 0.55 | 0.28 |
Other Receivables | 0.37 | 5.56 | 8.77 | 0.41 | 0.2 |
Receivables | 0.46 | 14.02 | 17.89 | 0.96 | 0.48 |
Inventory | 0.03 | 0.05 | - | - | - |
Prepaid Expenses | 0.01 | 0.04 | 0.01 | 0.07 | 0.03 |
Other Current Assets | - | - | - | - | -0 |
Total Current Assets | 1.55 | 14.21 | 18.12 | 1.25 | 2.47 |
Property, Plant & Equipment | 0.74 | 0.27 | 0.39 | 0.54 | 0.67 |
Long-Term Investments | 251.64 | 245.31 | 203.01 | 182.44 | 156.65 |
Goodwill | - | 0.02 | 0.02 | - | - |
Other Intangible Assets | 253.68 | 269.18 | 285.05 | 300.91 | 316.67 |
Other Long-Term Assets | 0 | 4.44 | -0 | 0 | -0 |
Total Assets | 517.12 | 540.37 | 511.99 | 490.23 | 480.06 |
Liabilities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 0.34 | 1.03 | 0.97 | 0.63 | 0.38 |
Short-Term Debt | 6.52 | 5.25 | 0.84 | - | - |
Current Portion of Leases | 0.11 | 0.11 | 0.11 | 0.11 | - |
Current Unearned Revenue | 6.49 | 2 | 3.32 | 0.93 | 1.68 |
Other Current Liabilities | 1.46 | 0.87 | 0.59 | 0.27 | 0.27 |
Total Current Liabilities | 14.93 | 9.26 | 5.83 | 1.93 | 2.33 |
Long-Term Debt | 53.37 | 53.89 | 55.57 | 60.24 | 62.97 |
Long-Term Leases | 0.57 | 0.07 | 0.18 | 0.28 | 0.5 |
Pension & Post-Retirement Benefits | 0.06 | 0.06 | 0.07 | 0.03 | 0.11 |
Long-Term Deferred Tax Liabilities | 75.83 | 80.57 | 85.31 | 90.05 | 94.94 |
Other Long-Term Liabilities | 0 | - | -0 | - | 0 |
Total Liabilities | 144.76 | 143.85 | 146.96 | 152.53 | 160.85 |
Shareholders' Equity
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 5.77 | 5.74 | 5.59 | 5.28 | 5.06 |
Retained Earnings | 116.4 | 137.95 | 103.67 | 88.79 | 74.48 |
Treasury Stock | -1.38 | - | - | - | - |
Comprehensive Income & Other | 165.74 | 161.57 | 158.91 | 141.16 | 131.69 |
Total Common Equity | 286.53 | 305.26 | 268.17 | 235.23 | 211.23 |
Minority Interest | 85.83 | 91.26 | 96.86 | 102.47 | 107.98 |
Shareholders' Equity | 372.36 | 396.52 | 365.04 | 337.7 | 319.22 |
Total Liabilities & Equity | 517.12 | 540.37 | 511.99 | 490.23 | 480.06 |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 60.57 | 59.32 | 56.7 | 60.63 | 63.47 |
Net Cash (Debt) | -59.52 | -59.22 | -56.48 | -60.41 | -61.51 |
Net Cash Growth | - | - | - | - | - |
Net Cash Per Share | -10.38 | -8.07 | -7.80 | -8.33 | -9.94 |
Filing Date Shares Outstanding | 5.7 | 5.74 | 5.7 | 5.34 | 5.28 |
Total Common Shares Outstanding | 5.7 | 5.74 | 5.59 | 5.28 | 5.06 |
Working Capital | -13.38 | 4.95 | 12.29 | -0.68 | 0.14 |
Book Value Per Share | 50.25 | 53.16 | 47.95 | 44.52 | 41.75 |
Tangible Book Value | 32.84 | 36.06 | -16.9 | -65.68 | -105.44 |
Tangible Book Value Per Share | 5.76 | 6.28 | -3.02 | -12.43 | -20.84 |
Machinery | 0.26 | 0.26 | 0.24 | 0.23 | 0.21 |